Michael A. Kozminski

Michael A. Kozminski

Urology

245 Cherry Street SE
Suite 202
Grand Rapids, MI 49503

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses.

The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses.

Journal: Urologic oncology

Published: July 25, 2024

Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.

Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.

Journal: Urologic oncology

Published: December 26, 2015

Symptomatic subcapsular and perinephric hematoma following ureteroscopic lithotripsy for renal calculi.

Symptomatic subcapsular and perinephric hematoma following ureteroscopic lithotripsy for renal calculi.

Journal: Journal of endourology

Published: July 16, 2014

Reply: To PMID 24958478.

Reply: To PMID 24958478.

Journal: Urology

Published: June 25, 2014

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Journal: BJU international

Published: May 15, 2014

Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.

Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.

Journal: Urology

Published: December 10, 2013

Showing 1-6 of 6

Last Updated: 09/26/2026